Skip to main content
Erschienen in: Translational Stroke Research 3/2018

03.11.2017 | Original Article

Pre-existing Small Vessel Disease in Patients with Acute Stroke from the Middle East, Southeast Asia, and Philippines

verfasst von: Naveed Akhtar, Abdul Salam, Saadat Kamran, Atlantic D’Souza, Yahia Imam, Ahmed Own, Ahmed ElSotouhy, Surjith Vattoth, Paula Bourke, Zain Bhutta, Sujatha Joseph, Mark Santos, Rabia Ali Khan, Ashfaq Shuaib

Erschienen in: Translational Stroke Research | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Asymptomatic small vessel disease (SVD), including white matter hyperintensities (WMHIs), periventricular hyperintensities (PVHIs), silent stroke (SS), and cerebral microbleeds (CMBs), increases the risk of stroke. There are limited studies of SVD in subjects from the Middle East and Southeast Asia (SA). All patients admitted to stroke service between 2014 and 2015 were reviewed for presence of “pre-existing” SVD. Stroke mimics with no previous history of stroke were used as controls. There were 1727 patients admitted with stroke. Analysis was done on 988 subjects (914 strokes and 74 controls) who had MRI scan done. Pre-existing SVD was seen in 642 (64.9%) patients (WMHIs 19.6%, PVHIs 33.2%, SS 51.4%, and CMBs 22%). Silent strokes were significantly more common with ischemic stroke (IS) compared to intracranial hemorrhage (ICH) (62.0 vs 34.3%, p < 0.001). CMBs were more in ICH compared to IS (42.9 vs 23.1%, p < 0.001). The risk of developing CMBs among Far Eastern (FE) patients was 1.58 times more (p = 0.07), while 1.48 times more in Arabs (AR) (p = 0.026) compared to SA after adjusting for age. The risk of developing PVHIs was significantly higher in Arab compared to SA (odds ratio (OR) 1.43; p value = 0.021). Similarly, the risk of developing WMHIs was also significantly higher in AR patients (OR 1.6; p value = 0.009) compared to SA. The majority of ethnic AR, SA, and FE populations show pre-existing SVD on MRI. The advanced changes at a young age may be related to high prevalence of untreated risk factors and possibly as yet defined genetic and environmental factors.
Literatur
1.
Zurück zum Zitat Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701.CrossRefPubMed Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701.CrossRefPubMed
2.
Zurück zum Zitat Lan KK, Li L, Schulz U, Simoni M, Chan KH, Ho SL, et al. Total small vessel disease score and the risk of recurrent stroke. Neurology. 2017;88:2260–7.CrossRef Lan KK, Li L, Schulz U, Simoni M, Chan KH, Ho SL, et al. Total small vessel disease score and the risk of recurrent stroke. Neurology. 2017;88:2260–7.CrossRef
3.
Zurück zum Zitat Romero JR, Preis SR, Beiser A, DeCarli C, Viswanathan A, Martinez-Ramirez S, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke. 2014;45:1492–4.CrossRefPubMedPubMedCentral Romero JR, Preis SR, Beiser A, DeCarli C, Viswanathan A, Martinez-Ramirez S, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke. 2014;45:1492–4.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Portegies MLP, Wolters FJ, Hofman A, Ikram MK, Koudstaal PJ, Ikram MA. Prestroke vascular pathology and the risk of recurrent stroke and poststroke dementia. Stroke. 2016;47:2119–22.CrossRefPubMed Portegies MLP, Wolters FJ, Hofman A, Ikram MK, Koudstaal PJ, Ikram MA. Prestroke vascular pathology and the risk of recurrent stroke and poststroke dementia. Stroke. 2016;47:2119–22.CrossRefPubMed
5.
Zurück zum Zitat Kuller LH, Longstreth WT, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke. 2004;35:1821–5.CrossRefPubMed Kuller LH, Longstreth WT, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke. 2004;35:1821–5.CrossRefPubMed
6.
Zurück zum Zitat Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Salman RA, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165–74.CrossRefPubMedPubMedCentral Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Salman RA, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165–74.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Gupta A, Giambrone AE, Gialdini G, Finn C, Delgado D, Gutierrez J, et al. Silent brain infarction and the risk of future stroke. A systemic meta-analysis. Stroke. 2016;47:719–25.PubMedPubMedCentralCrossRef Gupta A, Giambrone AE, Gialdini G, Finn C, Delgado D, Gutierrez J, et al. Silent brain infarction and the risk of future stroke. A systemic meta-analysis. Stroke. 2016;47:719–25.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved. Lancet Neurol. 2007;6:94–7.CrossRefPubMed Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved. Lancet Neurol. 2007;6:94–7.CrossRefPubMed
9.
Zurück zum Zitat O’Donnell M, Yousef S. Tracking the global burden of stroke: the need for large scale international studies. Lancet Neurol. 2009;8:306–7.CrossRefPubMed O’Donnell M, Yousef S. Tracking the global burden of stroke: the need for large scale international studies. Lancet Neurol. 2009;8:306–7.CrossRefPubMed
10.
Zurück zum Zitat Wasay M, Khatri IA, Kaul S. Stroke in South Asian countries. Nat Rev Neurol. 2014;10:135–43.CrossRefPubMed Wasay M, Khatri IA, Kaul S. Stroke in South Asian countries. Nat Rev Neurol. 2014;10:135–43.CrossRefPubMed
11.
Zurück zum Zitat Johnson SC, Mendis S, Mathers CD. Global variations in stroke burden and mortality: estimates from monitoring, surveillance and modelling. Lancet Neurol. 2009;8:345–54.CrossRef Johnson SC, Mendis S, Mathers CD. Global variations in stroke burden and mortality: estimates from monitoring, surveillance and modelling. Lancet Neurol. 2009;8:345–54.CrossRef
12.
Zurück zum Zitat O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, A-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112–23.CrossRefPubMed O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, A-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112–23.CrossRefPubMed
13.
Zurück zum Zitat Mehndiratta MM, Khan M, Mehndiratta P, Wasay M. Stroke in Asia: geographical variations and temporal trends. J Neurol Neurosurg Psychiatry. 2014;85:1308–12.CrossRefPubMed Mehndiratta MM, Khan M, Mehndiratta P, Wasay M. Stroke in Asia: geographical variations and temporal trends. J Neurol Neurosurg Psychiatry. 2014;85:1308–12.CrossRefPubMed
14.
Zurück zum Zitat Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. Global burden of stroke and risk factors in 188 countries during 1988-2013. Lancet Neurol. 2016;15:913–24.CrossRefPubMed Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. Global burden of stroke and risk factors in 188 countries during 1988-2013. Lancet Neurol. 2016;15:913–24.CrossRefPubMed
15.
Zurück zum Zitat Akhtar N, Salam A, Kamran S, Bourke P, Joseph S, Santos M, et al. Ethnic variation in acute cerebrovascular disease: analysis from the Qatar stroke registry. Eur Stroke Jour. 2016;1:231–41.CrossRef Akhtar N, Salam A, Kamran S, Bourke P, Joseph S, Santos M, et al. Ethnic variation in acute cerebrovascular disease: analysis from the Qatar stroke registry. Eur Stroke Jour. 2016;1:231–41.CrossRef
16.
Zurück zum Zitat Akhtar N, Kamran S, Singh R, Cameron P, D’Souza A, Imam Y, et al. Beneficial effects of implementing stroke protocols require establishment of a geographically distinct unit. Stroke. 2015;46:3494–501.CrossRefPubMed Akhtar N, Kamran S, Singh R, Cameron P, D’Souza A, Imam Y, et al. Beneficial effects of implementing stroke protocols require establishment of a geographically distinct unit. Stroke. 2015;46:3494–501.CrossRefPubMed
18.
Zurück zum Zitat Adam HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.CrossRef Adam HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.CrossRef
19.
Zurück zum Zitat Brant-Zawadzki M, Fein G, Van Dyke C, Kiernan R, Davenport L, de Groot J, et al. MR imaging of the aging brain: patchy white-matter lesions and dementia. AJNR. 1985;6:675–82.PubMed Brant-Zawadzki M, Fein G, Van Dyke C, Kiernan R, Davenport L, de Groot J, et al. MR imaging of the aging brain: patchy white-matter lesions and dementia. AJNR. 1985;6:675–82.PubMed
20.
Zurück zum Zitat Zimmerman RD, Fleming CA, Lee BCP, Saint-Louis LA, Deck MD. Peri ventricular hyperintensity as seen by magnetic resonance: prevalence and significance. AJR. 1986;146:443–50. AJNR .1986;7: 13–20CrossRefPubMed Zimmerman RD, Fleming CA, Lee BCP, Saint-Louis LA, Deck MD. Peri ventricular hyperintensity as seen by magnetic resonance: prevalence and significance. AJR. 1986;146:443–50. AJNR .1986;7: 13–20CrossRefPubMed
21.
Zurück zum Zitat Fazekas F, Chawlak JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol. 1987;149:351–6.CrossRef Fazekas F, Chawlak JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol. 1987;149:351–6.CrossRef
22.
Zurück zum Zitat Kakar P, Charidimou A, Werring DJ. Cerebral microbleeds: new dilemma in stroke medicine. JRSM Cardiovasc Dis. 2012;1:22. Kakar P, Charidimou A, Werring DJ. Cerebral microbleeds: new dilemma in stroke medicine. JRSM Cardiovasc Dis. 2012;1:22.
23.
Zurück zum Zitat Charidimou A, Jäger HR, Werring DJ. Cerebral microbleed detection and mapping: principles, methodological aspects and rationale in vascular dementia. Exp Gerontol. 2012;47:843–52.CrossRefPubMed Charidimou A, Jäger HR, Werring DJ. Cerebral microbleed detection and mapping: principles, methodological aspects and rationale in vascular dementia. Exp Gerontol. 2012;47:843–52.CrossRefPubMed
24.
Zurück zum Zitat Pasquini M, Bebedictus MR, Boulouis G, Rossi C, Dequatre-Ponchelle N, Cordonnier C. Incident cerebral microbleeds in a cohort of intracerebral hemorrhage. Stroke. 2016;47:689–94.PubMedCrossRef Pasquini M, Bebedictus MR, Boulouis G, Rossi C, Dequatre-Ponchelle N, Cordonnier C. Incident cerebral microbleeds in a cohort of intracerebral hemorrhage. Stroke. 2016;47:689–94.PubMedCrossRef
25.
Zurück zum Zitat Wang Y, Liu G, Hong D, Chen F, Ji X, Cao G. White matter injury and ischemic stroke. Prog Neurobiology. 2016;141:45–60.CrossRef Wang Y, Liu G, Hong D, Chen F, Ji X, Cao G. White matter injury and ischemic stroke. Prog Neurobiology. 2016;141:45–60.CrossRef
26.
Zurück zum Zitat Kleining TJ. Associations and implications of cerebral microbleeds. J Clin Neurosci. 2013;20:919–27.CrossRef Kleining TJ. Associations and implications of cerebral microbleeds. J Clin Neurosci. 2013;20:919–27.CrossRef
27.
Zurück zum Zitat Wong T, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, et al. Cerebral white matter lesions, retinopathy and incident clinical stroke. JAMA. 2002;288:67–74.CrossRefPubMed Wong T, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, et al. Cerebral white matter lesions, retinopathy and incident clinical stroke. JAMA. 2002;288:67–74.CrossRefPubMed
28.
Zurück zum Zitat Smith EE, Saposnik G, Biessels GJ, Doubal FN, Fornage M, Gorelick PB, et al. Prevention of stroke in patients with silent cerebrovascular disease. Stroke. 2017;48:e44–71.CrossRefPubMed Smith EE, Saposnik G, Biessels GJ, Doubal FN, Fornage M, Gorelick PB, et al. Prevention of stroke in patients with silent cerebrovascular disease. Stroke. 2017;48:e44–71.CrossRefPubMed
Metadaten
Titel
Pre-existing Small Vessel Disease in Patients with Acute Stroke from the Middle East, Southeast Asia, and Philippines
verfasst von
Naveed Akhtar
Abdul Salam
Saadat Kamran
Atlantic D’Souza
Yahia Imam
Ahmed Own
Ahmed ElSotouhy
Surjith Vattoth
Paula Bourke
Zain Bhutta
Sujatha Joseph
Mark Santos
Rabia Ali Khan
Ashfaq Shuaib
Publikationsdatum
03.11.2017
Verlag
Springer US
Erschienen in
Translational Stroke Research / Ausgabe 3/2018
Print ISSN: 1868-4483
Elektronische ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-017-0578-7

Weitere Artikel der Ausgabe 3/2018

Translational Stroke Research 3/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.